Human CCL2/JE/MCP-1 Antibody AB-279-NA from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman CCL2/JE/MCP-1 Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price $399.00Supplier Page View Company Product Page
Catalog NumberAB-279-NA
Quantity1 mg
ApplicationsWestern Blot,Neutralization
Conjugate/TagUnconjugated
FormatLyophilized from a 0.2 µm filtered solution in PBS and NaCl with Trehalose
ConcentrationLYOPH
PurityProtein A or G purified
ReactivityHuman
HostGoat
TargetCCL2/JE/MCP-1
IsotypeIgG
Antibody TypePrimary Antibodies
NCBI Gene AliasesMCP1, MCAF, HSMCR30, HC11, SMC-CF, GDCF-2, SCYA2, MCP-1
NCBI Full Gene NameC-C motif chemokine ligand 2
ClonalityPolyclonal
ImmunogenE. coli-derived recombinant human CCL2/JE/MCP-1, Gln24-Thr99, Accession # P13500
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution

Specifications/Features

Available conjugates: Unconjugated

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Adipocytes Promote Early Steps of Breast Cancer Cell Dissemination via Interleukin-8Frontiers in immunologyJanuary 1, 2018Vazquez Rodriguez G, Abrahamsson A, Jensen LDE, Dabrosin C.µg/ml, and rabbit anti-human IL-8, rabbit anti-human VEGF, goat anti-human CCL2 (R and D Systems Cat# AB-279-NA, RRID:AB_354333), goat anti-human CCL5 (R and D Systems Cat# AB-278-NA, RRID:AB_354332), mouse anti-human

(2) Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expressionPloS oneJanuary 1, 2013Liu Z, Xu J, Li H, Zheng Y, He J, Liu H, Zhong Y, Lu Y, Hong B, Zhang M, et al.

(3) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growthNature medicineOctober 30, 2011Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, et al.proteins were used at the following concentrations: IL-6 (AB206NA) and IL-8 (AB208NA), 50 ng ml−1; MCP-1 (AB279NA), 100 μg ml−1; MMP-9 (EMD Chemicals, IM09L), 6 μg ml−1; TIMP-1, 100 ng ml−1. CMFDA-labeled SKOV3ip1

(4) Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cellsJournal of immunology (Baltimore, Md. : 1950)September 1, 2007Brown CE, Vishwanath RP, Aguilar B, Starr R, Najbauer J, Aboody KS, Jensen MC.chemotaxis. For immunodepletion studies, conditioned medium was incubated overnight with 0.02 mg/ml anti-hMCP1 (AB-279-NA; R&D Systems) or antihIL-8 (AB-208-NA; R&D Systems) Ab, followed by depletion of cytokine-Ab complexes

Be the First to Write a Review!

CCL2/JE/MCP-1 Antibody

CCL2/JE/MCP-1 Antibody

Human CCL2/JE/MCP-1 Antibody from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (4)

Reviews

Human CCL2/JE/MCP-1 Antibody from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map